Sengül Üçer
Sengül Üçer has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Sami Kinikli
Sağlık Bilimleri Üniversitesi, Ankara Eğitim ve Araştırma Hastanesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Kliniği, Ankara
3 shared publications - Esra Kaya Kiliç
Sağlık Bilimleri Üniversitesi, Ankara Eğitim ve Araştırma Hastanesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Kliniği, Ankara
2 shared publications - Gunay Tuncer Ertem
ANKARA EĞİTİM VE ARAŞTIRMA HASTANESİ, ENFEKSİYON HASTALIKLARI VE KLİNİK MİKROBİYOLOJİ
2 shared publications - Salih Cesur
ANKARA EĞİTİM VE ARAŞTIRMA HASTANESİ, ENFEKSİYON HASTALIKLARI VE KLİNİK MİKROBİYOLOJİ
2 shared publications - Çiğdem Ataman Hatipoğlu
Sağlık Bilimleri Üniversitesi, Ankara Eğitim ve Araştırma Hastanesi
2 shared publications - Şerife Altun Demircan
Sağlık Bilimleri Üniversitesi Ankara Eğitim ve Araştırma Hastanesi
2 shared publications
Latest Publications
- Open Access
- 21 August 2026
- Published by Duzce Medical Journal in Düzce Tıp Fakültesi Dergisi
- Vol. 28 (2) , 207-211
Evaluation of Hepatitis B Vaccination Coverage and Serological Response in People Living with HIV
Aim: People living with HIV (PLWH) face a heightened risk of acquiring hepatitis B virus (HBV) infection because these two viruses share common transmission pathways. HIV/HBV coinfection is associated with accelerated liver disease progression. Consequently, hepatitis B vaccination is a critical preventive measure for PLWH. This study was designed to assess the serological response to hepatitis B vaccination in PLWH.Material and Methods: PLWH followed at the Infectious Diseases and Clinical Microbiology Clinic who were seronegative for HBsAg, anti-HBs, and anti-HBc IgG were retrospectively identified. Anti-HBs levels measured 1 month to 1 year after the final vaccine dose were assessed. Criteria associated with low response (anti-HBs titer: <100 mIU/mL) and high response (≥100 mIU/mL) were also evaluated.Results: A total of 54 patients were included in the final analysis. The median age was 43 (range, 22–80) years and 25.9% of the patients were female. Forty-nine patients (90.7%) had anti-HBs levels ≥10 mIU/mL. Anti-HBs levels ≥100 mIU/mL were observed in 10 (28.6%) patients who had received at least one double-dose vaccination versus 3 (15.8%) patients who had not (p=0.341), and in 18 (51.4%) patients with undetectable HIV RNA versus 5 (26.3%) patients with detectable HIV RNA (p=0.091), without reaching statistical significance.Conclusion: Adherence to the hepatitis B vaccination schedule was found to be suboptimal. Identifying the underlying causes of poor vaccination adherence and implementing strategies to improve compliance are essential in PLWH.
- 21 August 2026
- Published by Duzce Medical Journal in Düzce Tıp Fakültesi Dergisi
- Vol. 28 (2) , 207-211
Open AccessEvaluation of Hepatitis B Vaccination Coverage and Serological Response in People Living with HIV
Aim: People living with HIV (PLWH) face a heightened risk of acquiring hepatitis B virus (HBV) infection because these two viruses share common transmission pathways. HIV/HBV coinfection is associated with accelerated liver disease progression. Consequently, hepatitis B vaccination is a critical preventive measure for PLWH. This study was designed to assess the serological response to hepatitis B vaccination in PLWH.Material and Methods: PLWH followed at the Infectious Diseases and Clinical Microbiology Clinic who were seronegative for HBsAg, anti-HBs, and anti-HBc IgG were retrospectively identified. Anti-HBs levels measured 1 month to 1 year after the final vaccine dose were assessed. Criteria associated with low response (anti-HBs titer: <100 mIU/mL) and high response (≥100 mIU/mL) were also evaluated.Results: A total of 54 patients were included in the final analysis. The median age was 43 (range, 22–80) years and 25.9% of the patients were female. Forty-nine patients (90.7%) had anti-HBs levels ≥10 mIU/mL. Anti-HBs levels ≥100 mIU/mL were observed in 10 (28.6%) patients who had received at least one double-dose vaccination versus 3 (15.8%) patients who had not (p=0.341), and in 18 (51.4%) patients with undetectable HIV RNA versus 5 (26.3%) patients with detectable HIV RNA (p=0.091), without reaching statistical significance.Conclusion: Adherence to the hepatitis B vaccination schedule was found to be suboptimal. Identifying the underlying causes of poor vaccination adherence and implementing strategies to improve compliance are essential in PLWH.
- 3 October 2024
- Published by Medical Journal of Ankara Training and Research Hospital in Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi
Complicated Intraabdominal Infections; Epidemiology of Microorganisms, Resistance Profiles ans Risk Factors Associated with Mortality
Aim: The threat of antimicrobial resistance has been identified as one of the major challenges in the management of complicated intra-abdominal infections(cIAIs). In this study, we aimed to describe the clinical, microbiological and resistance profiles of complicated intra-abdominal infections and to assess the risk factors related to resistance and mortality. Material and Method: Seventy-nine patients undergoing surgery or interventional drainage for cIAIs with a positive microbiological culture were documented. Results: Among these patients 79,7% were affected by health care associated IAIs while remaining 20,3% cases were identified as cIAI in the community. In 79 cases, 143 microorganisms were isolated and the leading microorganism was E.coli (34.9%) followed by Enterococcus spp. (17.4%). Among Enterobacteriaceae (n:96), 53.6% of the strains had ESBL and 36.8% were Multi Drug Resistant (MDR) bacteria. The overall mortality rate was 22.8%. According to univariate analysis, the use of broad spectrum antibiotics between initial intervention and re-operation was a significant risk factor for presence of ESBL. By multivariate analysis of the data; isolation of MDR bacteria, Enterococcus spp as an etiologic agent and presence of chronic obstructive pulmonary disease were statistically significant indicators for mortality. Discussion: These data indicate that local community and nosocomial resistance patterns should guide empiric antimicrobial therapy. Conclusion: To have the efficient data for resistance patterns, culture of the materials should not be neglected in either hospital or community acquired IAIs.Due to the increase in the prevalence of ESBL positive and MDR bacteria, demonstration of the epidemiological data in populations and each hospital is crucially important for accurate selection of initial empirical antibiotherapy
- 3 October 2024
- Published by Medical Journal of Ankara Training and Research Hospital in Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi
Complicated Intraabdominal Infections; Epidemiology of Microorganisms, Resistance Profiles ans Risk Factors Associated with Mortality
Aim: The threat of antimicrobial resistance has been identified as one of the major challenges in the management of complicated intra-abdominal infections(cIAIs). In this study, we aimed to describe the clinical, microbiological and resistance profiles of complicated intra-abdominal infections and to assess the risk factors related to resistance and mortality. Material and Method: Seventy-nine patients undergoing surgery or interventional drainage for cIAIs with a positive microbiological culture were documented. Results: Among these patients 79,7% were affected by health care associated IAIs while remaining 20,3% cases were identified as cIAI in the community. In 79 cases, 143 microorganisms were isolated and the leading microorganism was E.coli (34.9%) followed by Enterococcus spp. (17.4%). Among Enterobacteriaceae (n:96), 53.6% of the strains had ESBL and 36.8% were Multi Drug Resistant (MDR) bacteria. The overall mortality rate was 22.8%. According to univariate analysis, the use of broad spectrum antibiotics between initial intervention and re-operation was a significant risk factor for presence of ESBL. By multivariate analysis of the data; isolation of MDR bacteria, Enterococcus spp as an etiologic agent and presence of chronic obstructive pulmonary disease were statistically significant indicators for mortality. Discussion: These data indicate that local community and nosocomial resistance patterns should guide empiric antimicrobial therapy. Conclusion: To have the efficient data for resistance patterns, culture of the materials should not be neglected in either hospital or community acquired IAIs.Due to the increase in the prevalence of ESBL positive and MDR bacteria, demonstration of the epidemiological data in populations and each hospital is crucially important for accurate selection of initial empirical antibiotherapy
- Open Access
- 26 September 2024
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 6 (3) , 216-224
The Efficacy of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients and the Impact of the COVID-19 Pandemic: Multicenter Real-Life Data
In 75-85% of cases of acute hepatitis C infection, the disease becomes chronic and carries a risk of developing liver failure and hepatocellular cancer. In its global hepatitis report published in 2017, the World Health Organization (WHO) reported that 71.1 (95% uncertainty interval [UI]: 62.1-79.0 million) million people were chronically infected with the hepatitis C virus
- 26 September 2024
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 6 (3) , 216-224
Open AccessThe Efficacy of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients and the Impact of the COVID-19 Pandemic: Multicenter Real-Life Data
In 75-85% of cases of acute hepatitis C infection, the disease becomes chronic and carries a risk of developing liver failure and hepatocellular cancer. In its global hepatitis report published in 2017, the World Health Organization (WHO) reported that 71.1 (95% uncertainty interval [UI]: 62.1-79.0 million) million people were chronically infected with the hepatitis C virus
- Open Access
- 1 July 2024
- Published by Turkish Journal of Clinics and Laboratory in TURKISH JOURNAL of CLINICS and LABORATORY
- Vol. 15 (2) , 248-255
Clinical and Radiological Features of Pyogenic and Brucellar Spondylodiscitis
Aim: Since spondylodiscitis continues to be seen with increasing incidence; thus, starting antibiotherapy targeted towards the etiological agent is crucial for reducing complications and mortality. This study aimed to determine the clinical and radiological characteristics of spondylodiscitis’ causative microorganisms. Material and Methods: Patients hospitalized in the Department of Infectious Diseases and Clinical Microbiology with a diagnosis of spondylodiscitis between 2015 and 2023 were retrospectively evaluated. Results: Low back pain was present in 97.5% of the total 40 patients as the most common symptom. Tissue biopsy culture results were obtained for 21 (52.5%) patients, with culture positivity observed in five (12.5%) patients. Consumption of raw milk/dairy products in the anamnesis and fever were found to be statistically significantly higher in patients with brucellosis (p < 0.001, p = 0.015), whereas neurological deficits were significantly higher in the pyogenic group (p = 0.007). No significant differences were observed between the pyogenic and brucella spondylodiscitis groups in terms of laboratory parameters (sedimentation rate, C-reactive protein, white blood cell count) and magnetic resonance imaging findings. Conclusion: Since no distinctive clinical and radiological parameters were identified for distinguishing between brucellar and pyogenic spondylodiscitis, serological tests for brucellosis should be investigated when considering the diagnosis, particularly in endemic regions. In cases of pyogenic spondylodiscitis, empirical antibiotic use prior to pathogen isolation may lead to delays in diagnosis and appropriate treatment, potentially resulting in complications such as neurological deficits. Therefore, interventional methods for tissue biopsy culture should be planned before antibiotherapy, especially in patients who do not immediately require antibiotherapy.
- 1 July 2024
- Published by Turkish Journal of Clinics and Laboratory in TURKISH JOURNAL of CLINICS and LABORATORY
- Vol. 15 (2) , 248-255
Open AccessClinical and Radiological Features of Pyogenic and Brucellar Spondylodiscitis
Aim: Since spondylodiscitis continues to be seen with increasing incidence; thus, starting antibiotherapy targeted towards the etiological agent is crucial for reducing complications and mortality. This study aimed to determine the clinical and radiological characteristics of spondylodiscitis’ causative microorganisms. Material and Methods: Patients hospitalized in the Department of Infectious Diseases and Clinical Microbiology with a diagnosis of spondylodiscitis between 2015 and 2023 were retrospectively evaluated. Results: Low back pain was present in 97.5% of the total 40 patients as the most common symptom. Tissue biopsy culture results were obtained for 21 (52.5%) patients, with culture positivity observed in five (12.5%) patients. Consumption of raw milk/dairy products in the anamnesis and fever were found to be statistically significantly higher in patients with brucellosis (p < 0.001, p = 0.015), whereas neurological deficits were significantly higher in the pyogenic group (p = 0.007). No significant differences were observed between the pyogenic and brucella spondylodiscitis groups in terms of laboratory parameters (sedimentation rate, C-reactive protein, white blood cell count) and magnetic resonance imaging findings. Conclusion: Since no distinctive clinical and radiological parameters were identified for distinguishing between brucellar and pyogenic spondylodiscitis, serological tests for brucellosis should be investigated when considering the diagnosis, particularly in endemic regions. In cases of pyogenic spondylodiscitis, empirical antibiotic use prior to pathogen isolation may lead to delays in diagnosis and appropriate treatment, potentially resulting in complications such as neurological deficits. Therefore, interventional methods for tissue biopsy culture should be planned before antibiotherapy, especially in patients who do not immediately require antibiotherapy.
- 3 October 2023
- Published by Elsevier in Journal Français d'Ophtalmologie
- Vol. 47 (5) , 103965
Choroidal changes in Crimean-Congo hemorrhagic fever
- 3 October 2023
- Published by Elsevier in Journal Français d'Ophtalmologie
- Vol. 47 (5) , 103965
Choroidal changes in Crimean-Congo hemorrhagic fever
- Open Access
- 22 May 2023
- Published by MediHealth Academy in Journal of Pulmonology and Intensive Care
- Vol. 1 (2) , 38-41
A current approach to acute mediastinitis
Acute mediastinitis is still among the major causes of high mortality despite advances in antibiotic therapies, intensive care support, and novel diagnostic techniques. Mediastinitis may develop due to esophageal perforation, by a downward spread of neck infection, or after cardiothoracic surgery. While computed tomography is the most preferred imaging technique in diagnosis, broad-spectrum antibiotic therapy and surgical debridement are the mainstay of the treatment. It is essential to combine multiple interventions, such as appropriate antimicrobial prophylaxis, minimization of contamination, elimination of preoperative nasal S. aureus carriage, and the adoption of relevant surgical techniques, to prevent particularly postoperative mediastinitis.
- 22 May 2023
- Published by MediHealth Academy in Journal of Pulmonology and Intensive Care
- Vol. 1 (2) , 38-41
Open AccessA current approach to acute mediastinitis
Acute mediastinitis is still among the major causes of high mortality despite advances in antibiotic therapies, intensive care support, and novel diagnostic techniques. Mediastinitis may develop due to esophageal perforation, by a downward spread of neck infection, or after cardiothoracic surgery. While computed tomography is the most preferred imaging technique in diagnosis, broad-spectrum antibiotic therapy and surgical debridement are the mainstay of the treatment. It is essential to combine multiple interventions, such as appropriate antimicrobial prophylaxis, minimization of contamination, elimination of preoperative nasal S. aureus carriage, and the adoption of relevant surgical techniques, to prevent particularly postoperative mediastinitis.
- 20 January 2023
- Published by Galenos Yayinevi in Journal of Ankara University Faculty of Medicine
- Vol. 75 (4) , 508-514
The Role of Neutrophil to Lymphocyte Ratio, Platelet to Lymphocyte Ratio and Red Cell Distribution Width as Inflammatory Markers in Brucellosis
- 20 January 2023
- Published by Galenos Yayinevi in Journal of Ankara University Faculty of Medicine
- Vol. 75 (4) , 508-514
The Role of Neutrophil to Lymphocyte Ratio, Platelet to Lymphocyte Ratio and Red Cell Distribution Width as Inflammatory Markers in Brucellosis
- 11 January 2022
- Published by Turkish Journal of Academic Gastroenterology in Akademik Gastroenteroloji Dergisi
- Vol. 20 (3) , 136-142
Seroprevalence of Hepatitis A virus according to age groups in Northern Anatolia of Turkey
Background and Aims: Hepatitis A virus is a cause of acute viral hepatitis that infects millions of people worldwide each year and maintains its prominence in both adults and in childhood. The aim of this study was to determine the hepatitis A seroprevalence in different age groups in Çorum which is the reference center for northern part of central Anatolia and to make recommendations for hepatitis A vaccine according to age groups. Materials and Methods: This retrospective study was conducted between January 2017 and January 2020. Patients tested for anti-hepatitis A virus for any reasons were enrolled from the data of all patients admitted to our hospital which is the reference center of the region. Serum samples were analyzed by ELISA. S/CO values of ≥ 1.00 were considered positive for anti-hepatitis A virus immunoglobulin G and immunoglobulin M, respectively; results below this value were considered negative. Anti hepatitis A virus immunoglobulin G and anti-hepatitis A virus immunoglobulin M results of patients were analyzed according to age groups. Results: A total of 18817 anti-hepatitis A virus immunoglobulin G and immunoglobulin M assays were screened from the computerized database. 4244 assays were excluded for repeated tests from the same patients and inconclusive data. The study included 4115 patients with anti-hepatitis A virus immunoglobulin M and 10458 patients with anti-hepatitis A virus immunoglobulin G. Total anti-hepatitis A virus immunoglobulin G and M positivities were 84.4% and 0.7%. Anti-hepatitis A virus immunoglobulin G prevalence was – 85.8% and 83%, and anti-hepatitis A virus immunoglobulin M positivity was – 0.98% and 0.38% in men and women. There was a significant difference in the prevalence of hepatitis A virus immunoglobulin G and immunoglobulin M according to age groups in Çorum (p < 0.001, p = 0.035). Anti-hepatitis A virus immunoglobulin G seronegativity for 11 - 20 years of age was 28.4% and for 21 - 30 years of age was 24.2%. Conclusion: This study suggests that 11 - 20 and 21 - 30 years of age groups may be in the highest risk group for hepatitis A virus infection with possible complications increasing with age, and this patient group constitutes the target population for vaccination.
- 11 January 2022
- Published by Turkish Journal of Academic Gastroenterology in Akademik Gastroenteroloji Dergisi
- Vol. 20 (3) , 136-142
Seroprevalence of Hepatitis A virus according to age groups in Northern Anatolia of Turkey
Background and Aims: Hepatitis A virus is a cause of acute viral hepatitis that infects millions of people worldwide each year and maintains its prominence in both adults and in childhood. The aim of this study was to determine the hepatitis A seroprevalence in different age groups in Çorum which is the reference center for northern part of central Anatolia and to make recommendations for hepatitis A vaccine according to age groups. Materials and Methods: This retrospective study was conducted between January 2017 and January 2020. Patients tested for anti-hepatitis A virus for any reasons were enrolled from the data of all patients admitted to our hospital which is the reference center of the region. Serum samples were analyzed by ELISA. S/CO values of ≥ 1.00 were considered positive for anti-hepatitis A virus immunoglobulin G and immunoglobulin M, respectively; results below this value were considered negative. Anti hepatitis A virus immunoglobulin G and anti-hepatitis A virus immunoglobulin M results of patients were analyzed according to age groups. Results: A total of 18817 anti-hepatitis A virus immunoglobulin G and immunoglobulin M assays were screened from the computerized database. 4244 assays were excluded for repeated tests from the same patients and inconclusive data. The study included 4115 patients with anti-hepatitis A virus immunoglobulin M and 10458 patients with anti-hepatitis A virus immunoglobulin G. Total anti-hepatitis A virus immunoglobulin G and M positivities were 84.4% and 0.7%. Anti-hepatitis A virus immunoglobulin G prevalence was – 85.8% and 83%, and anti-hepatitis A virus immunoglobulin M positivity was – 0.98% and 0.38% in men and women. There was a significant difference in the prevalence of hepatitis A virus immunoglobulin G and immunoglobulin M according to age groups in Çorum (p < 0.001, p = 0.035). Anti-hepatitis A virus immunoglobulin G seronegativity for 11 - 20 years of age was 28.4% and for 21 - 30 years of age was 24.2%. Conclusion: This study suggests that 11 - 20 and 21 - 30 years of age groups may be in the highest risk group for hepatitis A virus infection with possible complications increasing with age, and this patient group constitutes the target population for vaccination.